The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares



Results

Search articles by EPIC code
NEWSFLOW NEWSFLOW NEWSFLOW

Novacyt: the desperate ramping continues as CEO Graham Mullis can almost smell your money

2020-09-04 11:40:36

Remember, as I warned you in my first ever video show, that bosses at Novacyt (NCYT) will get millions of pounds in a few weeks if they can keep the Novacyt share price where it is. The higher it goes, the more they get. They will get the bonus in hard cash, potentially exhausting most of the company’s bank balance in the process. What happens thereafter is of no consequence for Graham Mullis & co, October 17 is ching ching day. To that end, the company is in ramping overdrive and Mullis can now almost smell the cash heading into his bank account. 

ARTICLE NEWSFLOW NEWSFLOW

Novacyt – the desperate share-ramping continues: Reminder that October 17th is Noses in Trough day

2020-07-27 12:38:21

On my first weekly video show, I spelled out to you all why bosses at Novacyt (NCYT) will do absolutely everything they can to ramp the shares ahead of October 17. Every extra  penny on the share price on that day is worth more than ten thousand pounds to the CEO alone. In that vein, we have more ramptastic “news” today. But perhaps you are excited about a “second wave” of Covid deaths in Spain.

ARTICLE NEWSFLOW

Novacyt talking bullshit again

2020-07-13 13:37:56

Remember from episode 1, this is all about ramping the shares ahead of October 17. The higher the share price then the greater the size of the multi-million quid bonus pool for Novacyt (NCYT) bosses notably CEO Graham Mullis. Oink Oink. Ching. Ching.

ARTICLE NEWSFLOW ARTICLE NEWSFLOW

Novacyt Coronavirus update – when will the bandwagon shudder to a grinding halt

2020-06-02 12:04:25

In April and May we were at peak Covid hysteria. Across the world authorities like the disgraced Public Health England which had shamed themselves by having limited supplies of PPE and other items hastened to order as many Covid tests as they could. Now they are well stocked by testing at way under capacity. So what is going on and why should Novacyt (NCYT) care?

ARTICLE NEWSFLOW

Novacyt shareholder commits market abuse impersonating Tom Winnifrith to keep the ramp going

2020-05-26 08:30:01

In yesterday's new video show I explained why Novacyt (NCYT) shares were 90% overvalued and presented damning new evidence of the management ramp. Yet immediately a raft of twitter fools - who clearly do not listen to what I have repeatedly said about this stock  - accused me of a volte face? And one particularly deranged individual showed "evidence" of me ramping the stock on May 18. Hang on Henry! This is market abuse. It's personation. It's fraud.

ARTICLE

Novacyt Final results and trading outlook show valuation truly insane

2020-05-14 10:59:35

I do not deny, nor have I ever denied, that Novacyt (NCYT) is a winner from Coronavirus but the data out today must make you reflect on the past, present and future and conclude that the valuation, £213 million at 372p, is just insane.

ARTICLE

This Rocketing Virus Weapon is Worth Keeping an Eye on, Though I'm Avoiding it at the Mo

2020-04-08 09:25:10

Hello, Share Mashers. Most of you will be hopeful about the current rise in share prices. But when the real recovery finally gets underway, a few companies will deliver to rally their share prices to outdo previous levels. Obviously, a few medical companies could shine here. I’ve looked at a few contenders over the last fortnight, but here’s another one you may wish to keep track of...

 

ARTICLE

Novacyt is being pumped on coronavirus fears but my money would be on pharma giants like Roche to provide most of the tests - as Public Enemy rapped, 'Don't believe the hype'

2020-02-02 18:12:41

I wondered how long it would take before people started trying to cash in off of the back of coronavirus and pushing shares in small AIM listed companies that are supposedly going to make a fortune from this outbreak.

ARTICLE NEWSFLOW

Red Flags at Night – Novacyt death spiral: SELL

2019-05-06 08:58:13

AIM-listed diagnostics play Novacyt (NCYT) announced a death spiral deal on 23 April 2019 and at 6.23pm on Friday evening it slipped out details of the first two rounds of conversions – at no-one-is-watching o’clock….except ShareProphets was watching. It is also listed on the Euronext Growth market (ALNOV), and joined AIM at the back end of 2017 – since when it has been heading heavily southwards, as you can see from the chart below.

Search ShareProphets |

Recent Comments |




About ShareProphets

Contact Us

Advertise With Us

Send Us A Tip

Donate


Terms of Service

Privacy Policy

Cookie Policy


Forgot My Password

Forgot My Username

Resend Account Validation Token

Site by Everywhen